Home » Topics » Disease categories and therapies » Urology

Urology
RSS

KMD-3213: binding kinetics and pharmacological activity correlated in vivo

Oct. 25, 2000

Vivus withdraws Alibra NDA

Oct. 23, 2000

New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo

Oct. 19, 2000

Abbott researchers design novel water-soluble K+ channel openers

Oct. 17, 2000

Novel 5-HT reuptake inhibitors specifically claimed for use in premature ejaculation

Oct. 16, 2000

U.K. authorities clear new ED treatment for launch

Oct. 16, 2000

NitroMed describes improved methods of treating sexual dysfunction

Oct. 13, 2000

Mechanism of potential new treatment for erectile dysfunction elucidated

Oct. 13, 2000

Role for rho kinase inhibitors in the management of ED

Oct. 11, 2000

Synaptic's alpha1-adrenoceptors and BPH patents licensed to R.W. Johnson

Oct. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...